Is National Institute For Reproductive Health Inc Legit?

The National Institute For Reproductive Health Inc (NIRH) demonstrates a generally healthy financial position, marked by consistent revenue generation and substantial asset growth over the past decade. In the most recent filing (202306), the organization reported revenue of $7,762,978 against expenses of $5,040,735, resulting in a significant surplus. This positive trend is further supported by a robust asset base, which reached $10,741,241 in 202306, indicating strong financial reserves and capacity. While there were periods of deficit spending, such as in 201906 where expenses ($7,935,891) exceeded revenue ($5,113,364), the overall trajectory shows effective financial management and growth, particularly in recent years. NIRH's spending efficiency appears strong, with a notable surplus in the latest period. The organization's program spending is a significant component of its expenditures, reflecting a commitment to its mission. The absence of reported officer compensation across all available filings suggests a high degree of financial transparency and a focus on directing resources towards programmatic activities rather than executive salaries. This practice enhances public trust and indicates a lean operational structure at the executive level. Overall, NIRH exhibits good financial health, characterized by growing assets, positive net income in recent periods, and a transparent approach to executive compensation. The organization's ability to manage its finances effectively, even through periods of higher expenses, and its consistent growth in assets, positions it well for sustained impact. The lack of reported officer compensation is a significant positive indicator of its commitment to mission-driven spending.